+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Transfusion Devices Market by Product, Application, End User, Component, Mode, Distribution Channel, Technology - Global Forecast to 2030- Product Image
Blood Transfusion Devices Market by Product, Application, End User, Component, Mode, Distribution Channel, Technology - Global Forecast to 2030- Product Image
Sale

Blood Transfusion Devices Market by Product, Application, End User, Component, Mode, Distribution Channel, Technology - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010985
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Transfusion Devices Market grew from USD 4.40 billion in 2024 to USD 4.73 billion in 2025. It is expected to continue growing at a CAGR of 7.27%, reaching USD 6.71 billion by 2030.

Navigating the Complex World of Blood Transfusion Devices

The blood transfusion devices market stands at a pivotal juncture, driven by technological breakthroughs, evolving clinical protocols, and a heightened focus on patient safety. Devices such as apheresis systems, blood bags, collection sets, component separators, leukocyte reduction filters, and transfusion pumps have become critical tools in modern healthcare delivery. Each category encompasses advanced modalities-from double‐needle and single‐needle apheresis platforms to syringe and volumetric pump solutions-underpinning the efficiency and safety of transfusion procedures worldwide.

This executive summary distills the most salient trends reshaping the industry, from transformative innovations and regulatory recalibrations to the implications of new tariff policies. It also presents segmentation insights, regional dynamics, competitive profiling, and actionable recommendations. Designed for decision‐makers and technical leaders, this overview equips stakeholders with the context and clarity needed to chart strategic initiatives in a rapidly evolving market landscape.

Emerging Forces Redefining the Transfusion Technology Landscape

Innovation in transfusion technology is accelerating at an unprecedented pace. Automation of collection and separation processes has reduced variability, while integration of electronic flow control and sensor-based monitoring has elevated patient safety. The convergence of data analytics and device connectivity is enabling real-time quality assurance, predictive maintenance, and personalized transfusion protocols. As hospitals and blood banks strive to optimize inventory management and minimize waste, advanced software platforms are emerging as essential complements to hardware investments.

Simultaneously, regulatory bodies are imposing stricter quality standards and traceability requirements. Sustainability has become a priority, driving adoption of closed-system collection sets and pre-storage leukocyte reduction filters that reduce contamination risk and environmental impact. Patient-centric care models are fueling demand for portable, user-friendly pumps and collection devices that support ambulatory and community-based transfusion services.

Strategic alliances between device manufacturers, software innovators, and clinical institutions are becoming more prevalent. Collaborative research is accelerating the translation of novel separation techniques and biocompatible materials into commercial applications. These partnerships not only broaden product portfolios but also enhance access to emerging markets and specialized end users.

Assessing the Ripple Effects of 2025 US Tariff Adjustments

The tariff adjustments implemented by the United States in 2025 have introduced substantial shifts across global supply chains for medical devices. Increased duties on raw materials and finished components have elevated landed costs, compelling manufacturers to reassess sourcing strategies and price structures. These measures have created ripples along the value chain, from polymer and plastic processors to final assembly facilities, intensifying the need for cost optimization without compromising device quality.

Hospitals and blood centers are confronting higher procurement prices for critical consumables and equipment. Budget-constrained institutions are seeking alternate suppliers, negotiating long-term contracts, and exploring domestic manufacturing partnerships to mitigate exposure to import levies. At the same time, manufacturers are evaluating the feasibility of relocating production closer to key end-markets to contain shipping costs and reduce lead times.

To navigate tariff volatility, industry leaders are strengthening supply chain resilience through multi-sourcing, inventory pre-positioning, and hedging strategies. Emphasis on lean manufacturing, value engineering, and collaborative planning with logistics partners is helping to absorb cost pressures. Looking ahead, organizations that proactively realign their procurement and operational frameworks will be best positioned to sustain margin performance and maintain competitive pricing.

Deconstructing Market Segmentation to Reveal Hidden Opportunities

A nuanced understanding of market segmentation reveals where growth and differentiation intersect. Product segmentation spans apheresis systems-further divided into double-needle and single-needle configurations-blood bags in multi-pocket and single-pocket formats, blood collection sets offered as closed or open systems, component separators in automated and manual varieties, leukocyte reduction filters designed for bedside or pre-storage use, and transfusion pumps featuring syringe or volumetric mechanisms. Application segmentation encompasses apheresis with collection and therapeutic subtypes, blood collection split between apheresis and whole blood methods, component separation via centrifugation and filtration, leukocyte reduction differentiated by mechanical approach, and transfusion categorized into continuous and intermittent protocols.

End-user segmentation distinguishes blood banks and donation centers, including government and private operations, from hospitals composed of private and public facilities. Component segmentation focuses on plasma-cryoprecipitate and fresh frozen plasma-platelets through apheresis or pooled options, red blood cells, and white blood cells comprising granulocyte and lymphocyte concentrates. Mode segmentation highlights fully automated desktop and robotic solutions, manual processes, and semi-automated systems utilizing cartridge or cassette formats. Distribution channels range from direct sales and hospital pharmacies operating centralized or in-house models to online sales via B2B platforms or manufacturer websites, as well as retail pharmacy networks.

Technology segmentation differentiates conventional flow control through gravity-fed and pressure infusion methods from electronic flow control leveraging microprocessor and sensor-based architectures. This comprehensive segmentation framework uncovers niche opportunities for targeted innovation, optimized resource allocation, and tailored go-to-market strategies.

Regional Dynamics Shaping Global Transfusion Markets

In the Americas, established healthcare infrastructures and robust reimbursement mechanisms have driven steady demand for advanced transfusion devices. Leading regional players continue to invest in localized R&D and production capabilities, while emerging economies within the region are expanding their blood banking networks to address growing patient volumes.

Europe, the Middle East & Africa present a tapestry of regulatory environments and market maturity levels. Western Europe’s stringent quality standards foster innovation, whereas growth in Eastern Europe and the Middle East is propelled by expanding public health initiatives. Africa’s market is nascent but exhibits high potential as international aid programs and private-sector partnerships bolster capacity building.

Asia-Pacific stands out for its rapid adoption of automated and electronic control systems. Healthcare modernization programs across China, India, and Southeast Asia are accelerating procurement of high-throughput apheresis and separation platforms. Local manufacturers are also emerging, leveraging cost advantages to compete on both domestic and export markets.

Profiling Industry Leaders Driving Technological Advancement

Leading manufacturers are differentiating through innovation, strategic collaborations, and expansion into adjacent segments. Established device producers are integrating digital monitoring solutions and cloud-based analytics into their platforms to enhance safety and traceability. Simultaneously, agile technology firms are introducing point-of-care transfusion systems designed for decentralized healthcare settings.

Key industry participants are actively pursuing mergers and acquisitions to broaden their portfolios and consolidate market share. Partnerships with biotechnology companies have unlocked new avenues for component separation and cell therapy applications. Investment in manufacturing capacity across low-cost regions has further strengthened competitive positioning by improving lead times and reducing cost of goods sold.

Strategic Imperatives for Sustained Competitive Advantage

To maintain a leadership position, companies should accelerate investment in advanced automation and digital integration across the transfusion workflow. Deploying sensor-driven, electronic flow control systems and cloud-enabled analytics platforms can yield significant improvements in safety, quality assurance, and operational efficiency.

Strengthening supply chain resilience through multi-sourcing, near-shoring, and strategic partnerships is essential to mitigate the impact of tariff fluctuations and logistic disruptions. Organizations should also explore strategic entry into high‐growth emerging regions by tailoring devices to local regulatory requirements and clinical practices.

Finally, aligning product development with evolving regulatory standards, sustainability goals, and workforce training initiatives will ensure long-term compliance and customer loyalty. Cultivating a culture of continuous learning and cross‐functional collaboration will enable rapid adaptation to market shifts and technological advancements.

Rigorous Methodology Underpinning In-Depth Market Intelligence

This research employs a rigorous blend of primary and secondary data collection methods. Extensive interviews with clinical experts, procurement officers, and device engineers provided firsthand insights into operational challenges and technology adoption drivers. Concurrently, a thorough review of regulatory filings, patent databases, technical white papers, and industry publications ensured comprehensive coverage of evolving standards and innovations.

Data triangulation and analytical validation processes were implemented to enhance accuracy and reliability. Market intelligence platforms were leveraged to track shipment volumes, pricing trends, and supplier performance metrics. Insights were further corroborated through peer-reviewed literature and independent verification by subject-matter specialists.

Synthesizing Insights to Chart Future Pathways

The blood transfusion devices sector is undergoing a profound transformation driven by automation, data-driven quality management, and shifting global trade dynamics. Segment-specific opportunities have emerged through detailed analysis of product, application, end-user, component, mode, distribution channel, and technology layers. Regional variations underscore the need for tailored strategies in the Americas, EMEA, and Asia-Pacific.

By profiling leading companies and distilling actionable recommendations, this summary equips stakeholders to optimize their investments, fortify supply chains, and capitalize on emerging needs. Decision-makers who integrate these insights into their strategic planning will be well positioned to navigate market complexities and achieve sustainable growth.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product
    • Apheresis System
      • Double Needle
      • Single Needle
    • Blood Bag
      • Multi Pocket
      • Single Pocket
    • Blood Collection Set
      • Closed System
      • Open System
    • Component Separator
      • Automated Separator
      • Manual Separator
    • Leukocyte Reduction Filter
      • Bedside
      • Pre Storage
    • Transfusion Pump
      • Syringe
      • Volumetric
  • Application
    • Apheresis
      • Collection Apheresis
      • Therapeutic Apheresis
    • Blood Collection
      • Apheresis Collection
      • Whole Blood Collection
    • Component Separation
      • Centrifugation Based
      • Filtration Based
    • Leukocyte Reduction
      • Centrifugation Based
      • Filtration Based
    • Transfusion
      • Continuous Transfusion
      • Intermittent Transfusion
  • End User
    • Blood Banks & Donation Centers
      • Government Centers
      • Private Centers
    • Hospitals
      • Private Hospitals
      • Public Hospitals
  • Component
    • Plasma
      • Cryoprecipitate
      • Fresh Frozen Plasma
    • Platelets
      • Apheresis Platelets
      • Pooled Platelets
    • Red Blood Cells
    • White Blood Cells
      • Granulocyte Concentrates
      • Lymphocyte Concentrates
  • Mode
    • Automated
      • Fully Automated Desktop
      • Robotic Systems
    • Manual
    • Semi Automated
      • Cartridge Based
      • Cassette Based
  • Distribution Channel
    • Direct Sales
    • Hospital Pharmacies
      • Centralized
      • In House
    • Online Sales
      • B2B Platforms
      • Manufacturer Websites
    • Retail Pharmacies
  • Technology
    • Conventional Flow Control
      • Gravity Fed
      • Pressure Infusion
    • Electronic Flow Control
      • Microprocessor Based
      • Sensor Based
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Becton, Dickinson and Company
  • Fresenius Kabi AG
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Haemonetics Corporation
  • Baxter International Inc.
  • Grifols, S.A.
  • Macopharma SA
  • Cerus Corporation
  • Immucor, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Transfusion Devices Market, by Product
8.1. Introduction
8.2. Apheresis System
8.2.1. Double Needle
8.2.2. Single Needle
8.3. Blood Bag
8.3.1. Multi Pocket
8.3.2. Single Pocket
8.4. Blood Collection Set
8.4.1. Closed System
8.4.2. Open System
8.5. Component Separator
8.5.1. Automated Separator
8.5.2. Manual Separator
8.6. Leukocyte Reduction Filter
8.6.1. Bedside
8.6.2. Pre Storage
8.7. Transfusion Pump
8.7.1. Syringe
8.7.2. Volumetric
9. Blood Transfusion Devices Market, by Application
9.1. Introduction
9.2. Apheresis
9.2.1. Collection Apheresis
9.2.2. Therapeutic Apheresis
9.3. Blood Collection
9.3.1. Apheresis Collection
9.3.2. Whole Blood Collection
9.4. Component Separation
9.4.1. Centrifugation Based
9.4.2. Filtration Based
9.5. Leukocyte Reduction
9.5.1. Centrifugation Based
9.5.2. Filtration Based
9.6. Transfusion
9.6.1. Continuous Transfusion
9.6.2. Intermittent Transfusion
10. Blood Transfusion Devices Market, by End User
10.1. Introduction
10.2. Blood Banks & Donation Centers
10.2.1. Government Centers
10.2.2. Private Centers
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
11. Blood Transfusion Devices Market, by Component
11.1. Introduction
11.2. Plasma
11.2.1. Cryoprecipitate
11.2.2. Fresh Frozen Plasma
11.3. Platelets
11.3.1. Apheresis Platelets
11.3.2. Pooled Platelets
11.4. Red Blood Cells
11.5. White Blood Cells
11.5.1. Granulocyte Concentrates
11.5.2. Lymphocyte Concentrates
12. Blood Transfusion Devices Market, by Mode
12.1. Introduction
12.2. Automated
12.2.1. Fully Automated Desktop
12.2.2. Robotic Systems
12.3. Manual
12.4. Semi Automated
12.4.1. Cartridge Based
12.4.2. Cassette Based
13. Blood Transfusion Devices Market, by Distribution Channel
13.1. Introduction
13.2. Direct Sales
13.3. Hospital Pharmacies
13.3.1. Centralized
13.3.2. In House
13.4. Online Sales
13.4.1. B2B Platforms
13.4.2. Manufacturer Websites
13.5. Retail Pharmacies
14. Blood Transfusion Devices Market, by Technology
14.1. Introduction
14.2. Conventional Flow Control
14.2.1. Gravity Fed
14.2.2. Pressure Infusion
14.3. Electronic Flow Control
14.3.1. Microprocessor Based
14.3.2. Sensor Based
15. Americas Blood Transfusion Devices Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Blood Transfusion Devices Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Blood Transfusion Devices Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Becton, Dickinson and Company
18.3.2. Fresenius Kabi AG
18.3.3. Terumo Corporation
18.3.4. B. Braun Melsungen AG
18.3.5. Haemonetics Corporation
18.3.6. Baxter International Inc.
18.3.7. Grifols, S.A.
18.3.8. Macopharma SA
18.3.9. Cerus Corporation
18.3.10. Immucor, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. BLOOD TRANSFUSION DEVICES MARKET MULTI-CURRENCY
FIGURE 2. BLOOD TRANSFUSION DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD TRANSFUSION DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. BLOOD TRANSFUSION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. BLOOD TRANSFUSION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD TRANSFUSION DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DOUBLE NEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE NEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MULTI POCKET, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE POCKET, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED SEPARATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL SEPARATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BEDSIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRE STORAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SYRINGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY VOLUMETRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COLLECTION APHERESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY THERAPEUTIC APHERESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONTINUOUS TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INTERMITTENT TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GOVERNMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS PLATELETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY POOLED PLATELETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHITE BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GRANULOCYTE CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LYMPHOCYTE CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHITE BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FULLY AUTOMATED DESKTOP, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CARTRIDGE BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CASSETTE BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SEMI AUTOMATED, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRALIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY IN HOUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY B2B PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONVENTIONAL FLOW CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GRAVITY FED, BY REGION, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRESSURE INFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONVENTIONAL FLOW CONTROL, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ELECTRONIC FLOW CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 102. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MICROPROCESSOR BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 103. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SENSOR BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 104. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ELECTRONIC FLOW CONTROL, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHITE BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED, 2018-2030 (USD MILLION)
TABLE 127. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SEMI AUTOMATED, 2018-2030 (USD MILLION)
TABLE 128. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 130. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 131. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONVENTIONAL FLOW CONTROL, 2018-2030 (USD MILLION)
TABLE 133. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ELECTRONIC FLOW CONTROL, 2018-2030 (USD MILLION)
TABLE 134. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHITE BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SEMI AUTOMATED, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONVENTIONAL FLOW CONTROL, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ELECTRONIC FLOW CONTROL, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 165. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, 2018-2030 (USD MILLION)
TABLE 167. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, 2018-2030 (USD MILLION)
TABLE 168. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, 2018-2030 (USD MILLION)
TABLE 169. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, 2018-2030 (USD MILLION)
TABLE 170. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, 2018-2030 (USD MILLION)
TABLE 171. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, 2018-2030 (USD MILLION)
TABLE 172. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, 2018-2030 (USD MILLION)
TABLE 174. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
TABLE 175. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, 2018-2030 (USD MILLION)
TABLE 176. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, 2018-2030 (USD MILLION)
TABLE 177. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 178. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, 2018-2030 (USD MILLION)
TABLE 180. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 181. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 182. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 183. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 184. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHITE BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 185. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 186. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED, 2018-2030 (USD MILLION)
TABLE 187. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SEMI AUTOMATED, 2018-2030 (USD MILLION)
TABLE 188. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 190. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 191. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONVENTIONAL FLOW CONTROL, 2018-2030 (USD MILLION)
TABLE 193. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ELECTRONIC FLOW CONTROL, 2018-2030 (USD MILLION)
TABLE 194. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, 2018-2030 (USD MILLION)
TABLE 196. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, 2018-2030 (USD MILLION)
TABLE 197. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, 2018-2030 (USD MILLION)
TABLE 198. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, 2018-2030 (USD MILLION)
TABLE 199. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, 2018-2030 (USD MILLION)
TABLE 200. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, 2018-2030 (USD MILLION)
TABLE 201. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, 2018-2030 (USD MILLION)
TABLE 203. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
TABLE 204. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, 2018-2030 (USD MILLION)
TABLE 205. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, 2018-2030 (USD MILLION)
TABLE 206. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 207. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, 2018-2030 (USD MILLION)
TABLE 209. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 210. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 211. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 212. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 213. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHITE BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 214. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 215. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED, 2018-2030 (USD MILLION)
TABLE 216. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SEMI AUTOMATED, 2018-2030 (USD MILLION)
TABLE 217. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 219. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 220. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONVENTIONAL FLOW CONTROL, 2018-2030 (USD MILLION)
TABLE 222. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ELECTRONIC FLOW CONTROL, 2018-2030 (USD MILLION)
TABLE 223. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, 2018-2030 (USD MILLION)
TABLE 225. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, 2018-2030 (USD MILLION)
TABLE 226. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, 2018-2030 (USD MILLION)
TABLE 227. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, 2018-2030 (USD MILLION)
TABLE 228. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, 2018-2030 (USD MILLION)
TABLE 229. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, 2018-2030 (USD MILLION)
TABLE 230. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, 2018-2030 (USD MILLION)
TABLE 232. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
TABLE 233. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, 2018-2030 (USD MILLION)
TABLE 234. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, 2018-2030 (USD MILLION)
TABLE 235. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 236. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, 2018-2030 (USD MILLION)
TABLE 238. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 239. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 240. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 241. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 242. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHITE BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 243. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 244. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED, 2018-2030 (USD MILLION)
TABLE 245. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SEMI AUTOMATED, 2018-2030 (USD MILLION)
TABLE 246. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 248. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 249. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONVENTIONAL FLOW CONTROL, 2018-2030 (USD MILLION)
TABLE 251. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ELECTRONIC FLOW CONTROL, 2018-2030 (USD MILLION)
TABLE 252. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 253. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, 2018-2030 (USD MILLION)
TABLE 254. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, 2018-2030 (USD MILLION)
TABLE 255. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, 2018-2030 (USD MILLION)
TABLE 256. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, 2018-2030 (USD MILLION)
TABLE 257. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, 2018-2030 (USD MILLION)
TABLE 258. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, 2018-2030 (USD MILLION)
TABLE 259. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, 2018-2030 (USD MILLION)
TABLE 261. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
TABLE 262. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, 2018-2030 (USD MILLION)
TABLE 263. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, 2018-2030 (USD MILLION)
TABLE 264. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 265. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, 2018-2030 (USD MILLION)
TABLE 267. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 268. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 269. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 270. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 271. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHITE BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 272. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 273. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED, 2018-2030 (USD MILLION)
TABLE 274. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SEMI AUTOMATED, 2018-2030 (USD MILLION)
TABLE 275. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 277. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 278. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONVENTIONAL FLOW CONTROL, 2018-2030 (USD MILLION)
TABLE 280. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ELECTRONIC FLOW CONTROL, 2018-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, 2018-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, 2018-2030 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, 2018-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, 2018-2030 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, 2018-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, 2018-2030 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, 2018-2030 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, 2018-2030 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, 2018-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, 2018-2030 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, 2018-2030 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, 2018-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, 2018-2030 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHITE BLOOD CELLS, 2018-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED, 2018-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SEMI AUTOMATED, 2018-2030 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONVENTIONAL FLOW CONTROL, 2018-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY ELECTRONIC FLOW CONTROL, 2018-2030 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES

Companies Mentioned

The companies profiled in this Blood Transfusion Devices market report include:
  • Becton, Dickinson and Company
  • Fresenius Kabi AG
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Haemonetics Corporation
  • Baxter International Inc.
  • Grifols, S.A.
  • Macopharma SA
  • Cerus Corporation
  • Immucor, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.73 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.71 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Blood Transfusion Devices - Global Strategic Business Report - Product Image

Blood Transfusion Devices - Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
Blood Transfusion Devices Market Report 2025 - Product Image

Blood Transfusion Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Blood Transfusion Diagnostics Market by Product, Technology, End User, Application - Global Forecast to 2030 - Product Image

Blood Transfusion Diagnostics Market by Product, Technology, End User, Application - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Blood Transfusion Diagnostics Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Blood Transfusion Diagnostics Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 158 Pages
  • Global
From
Blood Transfusion Diagnostics - Global Strategic Business Report - Product Image

Blood Transfusion Diagnostics - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From

About the Transfusion Equipment Market

The Transfusion Equipment market within the Blood Banking industry is composed of a variety of products and services used to collect, store, and distribute blood and blood components. This includes blood collection systems, blood storage systems, blood component separators, and blood transfusion systems. These products are used to ensure the safety and quality of the blood supply, as well as to improve the efficiency of the transfusion process. The Transfusion Equipment market is highly competitive, with a number of companies offering a wide range of products and services. Major players in the market include B. Braun, Fresenius Kabi, Haemonetics, Grifols, Terumo, and Macopharma. Other companies in the market include Biotest, Bio-Rad, Immucor, and Ortho Clinical Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.